Skip to main content
. 2015 Oct 13;4:1062. [Version 1] doi: 10.12688/f1000research.7111.1

Figure 4. Detection of resistance-associated variants after DAA treatment failure.

Figure 4.

VL and RAV status for three patients who failed to achieve sustained virological response after Telaprevir-based therapy. Grey shading: duration of therapy (weeks starting at time 0); squares: VL measurements; inverted triangles: samples sequenced using the comprehensive probe panel (open: no Telaprevir RAVs detected, black: RAVs and supporting read proportions, where <100%).